Denver Nephrology’s physicians are Certified by the American Board of Internal Medicine—Subspecialty of Nephrology. We provide consultative and ongoing care for patients with a myriad of kidney-related conditions such as systemic lupus erythematosis, diabetes mellitus, hypertension, kidney stones, inherited kidney disorders such as polycystic kidney disease, nephrotic syndrome, glomerulonephritis, and acute and chronic renal failure. In addition to our interest in hemodialysis therapy for the majority of our patients with End Stage Renal Disease (ESRD), we care for a large population of patients on home modalities of dialysis, including CAPD, CCPD and Home Hemodialysis. We are also the Medical Directors of the Kidney Transplant Program at Presbyterian-St. Lukes Medical Center in Denver.
The Clinical Research Division at Denver Nephrology is actively engaged in multiple projects and clinical trials, including the investigation of new erythropoietic agents and new parenteral iron therapies for treatment of anemia associated with CKD, the effects of the calcimimetic agent sinacalcet (sensipar) on suppression of parathyroid hormone in both ESRD and CKD patient populations, and cardiac and vascular calcification and their potential association with phosphate binder choice in ESRD patients.